Pricing Log in Create free account

Alector, Inc. (ALEC) vs InflaRx N.V. (IFRX)

Alector, Inc. and InflaRx N.V. are both Biotechnology companies. Alector, Inc. and InflaRx N.V. are of similar size ($213.3M and $212.2M). Alector, Inc. grew revenue faster over the last twelve months: −82.9% against −83.4%. InflaRx N.V. has the higher net margin (0.00% vs −850.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, InflaRx N.V. leads on 11 and Alector, Inc. on 4.

Valuation

Metric ALEC IFRX Biotechnology median
P/E n/m n/m 8.50
P/S 14.76 5,075.70 9.71
P/B n/m 0.91 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.71 0.64
EV/Sales 3.61 (1,061.22) 9.21
Earnings yield (59.78%) (43.94%) (33.15%)
Free cash flow yield (77.40%) (17.60%) (25.50%)

Profitability

Metric ALEC IFRX Biotechnology median
Gross margin 100.00% (26,762.42%) 65.16%
Operating margin (912.40%) 0.00% 0.00%
Net margin (850.13%) 0.00% 0.00%
Free cash flow margin (1,142.55%) 0.00% 0.00%
Return on equity (385.11%) (38.71%) (56.36%)
Return on assets (42.15%) (32.75%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALEC IFRX Biotechnology median
Revenue growth (TTM) (82.91%) (83.39%) 6.02%
EPS growth (last fiscal year) (13.01%) 9.41% 30.26%
Revenue growth, 5-year CAGR (0.05%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALEC IFRX Biotechnology median
Debt to equity (0.99) 0.00 0.00
Current ratio 5.26 8.22 4.72
Net debt to EBITDA 1.61 0.97 0.96

Dividend

Metric ALEC IFRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALEC IFRX Biotechnology median
Market cap 213.27m 212.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack